Related Experiment Video
Updated: Jun 10, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Proteins that bind the Src homology 3 domain of CrkI have distinct roles in Crk transformation
1Raymond and Beverly Sackler Laboratory of Genetics and Molecular Medicine, Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT 06030-6403, USA.
Abstract:
The v-Crk oncogene product consists of two protein interaction modules, a Src homology 2 (SH2) domain and a Src homology 3 (SH3) domain. Overexpression of CrkI, the cellular homolog of v-Crk, transforms mouse fibroblasts, and elevated CrkI expression is observed in several human cancers. The SH2 and SH3 domains of Crk are required for transformation, but the identity of the critical cellular binding partners is not known. A number of candidate Crk SH3-binding proteins have been identified, including the nonreceptor tyrosine kinases c-Abl and Arg, and the guanine nucleotide exchange proteins C3G, SOS1 and DOCK180. The aim of this study is to determine which of these are required for transformation by CrkI. We found that short hairpin RNA-mediated knockdown of C3G or SOS1 suppressed anchorage-independent growth of NIH-3T3 cells overexpressing CrkI, whereas knockdown of SOS1 alone was sufficient to suppress tumor formation by these cells in nude mice. Knockdown of C3G was sufficient to revert morphological changes induced by CrkI expression. By contrast, knockdown of Abl family kinases or their inhibition with imatinib enhanced anchorage-independent growth and tumorigenesis induced by Crk. These results show that SOS1 is essential for CrkI-induced fibroblast transformation, and also reveal a surprising negative role for Abl kinases in Crk transformation.
Insights
CrkI protein transformation of fibroblasts requires SOS1, a guanine nucleotide exchange protein. Abl kinases surprisingly inhibit CrkI-induced transformation and tumor formation.
Area of Science:
- Oncogene biology
- Cellular transformation
- Cancer research
Background:
- The v-Crk oncogene and its cellular homolog CrkI possess Src homology 2 (SH2) and Src homology 3 (SH3) domains.
- CrkI overexpression transforms mouse fibroblasts and is implicated in human cancers.
- Crk's SH2 and SH3 domains are crucial for transformation, but binding partners remain unidentified.
Purpose of the Study:
- To identify essential cellular binding partners required for CrkI-induced fibroblast transformation.
- To elucidate the roles of candidate Crk SH3-binding proteins, including C3G, SOS1, DOCK180, and Abl kinases.
Main Methods:
- Short hairpin RNA (shRNA)-mediated knockdown of candidate binding partners in NIH-3T3 cells.
- Assessment of anchorage-independent growth and morphological changes.
- Evaluation of tumor formation in nude mice.
- Inhibition of Abl family kinases using imatinib.
Main Results:
- Knockdown of C3G or SOS1 suppressed anchorage-independent growth of CrkI-overexpressing NIH-3T3 cells.
- SOS1 knockdown alone suppressed tumor formation in vivo.
- C3G knockdown reverted CrkI-induced morphological changes.
- Abl kinase inhibition or knockdown enhanced anchorage-independent growth and tumorigenesis.
Conclusions:
- SOS1 is essential for CrkI-induced fibroblast transformation.
- Abl kinases play a negative regulatory role in Crk-mediated transformation.
- These findings identify key molecular players in Crk oncogene-driven cellular changes.
Related Concept Videos
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Receptor Tyrosine Kinases
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
TGF - β Signaling Pathway

